Cubist to promote AstraZeneca's Merrem IV in US Cubist Pharmaceuticals, Inc.has signed an exclusive agreement with AstraZeneca to promote and provide other support in the United States for Merrem IV (meropenem for injection), an established broad spectrum (carbapenem class) IV...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V - Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R) I.V.
(meropenem for injection),...
Cubist Pharma signs agreement with AstraZeneca Cubist Pharmaceuticals, Inc.announced that it has signed an exclusive agreement with AstraZeneca to promote and provide other support in the United States for MERREM(R) I.V.
(meropenem for injection), an established broad spectrum ...
Cubist Pharmaceutical to promote AstraZeneca€™s MERREM IV in US market Cubist Pharmaceuticals, Lexington-based biopharmaceutical company, has signed an exclusive agreement with AstraZeneca, one of the world's leading pharmaceutical company, to promote and provide other support in the United States for MERREM(R)...
Cubist Pharmaceutical to promote AstraZeneca's MERREM IV in US market Cubist Pharmaceuticals, Lexington-based biopharmaceutical company, has signed an exclusive agreement with AstraZeneca, one of the world's leading pharmaceutical company, to promote and provide other support in the United States for MERREM(R)...
A Cubist Masterstroke Once a pharma gets its first drug approved, one of the hardest things to do is to capture the spoils.It's easy to burn through boatloads of cash to market the drug, or to get cornered into a marginal commercialization deal and settle on...
A Cubist Masterstroke Once a pharma gets its first drug approved, one of the hardest things to do is to capture the spoils.It's easy to burn through boatloads of cash to market the drug, or to get cornered into a marginal commercialization deal and settle on...
Cubist Agrees to Promote AstraZeneca Antibiotic Cubist Pharmaceuticals, the Lexington, MA-based maker of the Cubicin antibiotic, said today , another intravenous antibiotic drug made by AstraZeneca.Cubist, (NASDAQ: CBST) will receive a minimum of $20 million a year in revenue under the...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Cubist Pharmaceuticals, Inc.(CBST) today announced that it has signed an exclusive agreement with AstraZeneca (AZN) to promote and provide other support in the United States for MERREM I.V.
(meropenem for injection), an...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Leverages Proven U.S.Acute Care Sales Organization Complements Cubists Gram-Positive CUBICIN Company Website: http://www.cubist.com LEXINGTON, Mass.
-- (Business Wire) Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) today announced that...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, Merrem I.V - Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R) I.V.
(meropenem for injection),...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V AM Eastern Daylight Time Permalink To save a permanent link to this news, right-click the date and time (Ctl-click on a Mac) and choose the command to copy the link, link location or shortcut.Leverages Proven U.S.
Acute Care Sales...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc.(NASDAQ: CBST - News) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN - News) to promote and provide other support in the United States...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc.(NASDAQ: CBST - News) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN - News) to promote and provide other support in the United States...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V , 6:30 AM EST News source: Business Wire Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R)...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V LEXINGTON, Mass.(Business Wire) -- Cubist Pharmaceuticals, Inc.
(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R) I.V.
(meropenem for injection), an...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals Cubist Executive Vice President and Chief Operating Officer Robert J.Perez said of the agreement: 'As a broad spectrum antibiotic, MERREM I.V.
is an excellent fit with our...
Cubist Pharma, AstraZeneca sign exclusive deal to promote Merrem I.V. in US - Quick Facts (RTTNews) - Cubist Pharmaceuticals, Inc.(CBST: News, Chart, Quote ) said that it signed an exclusive agreement with AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) to promote and provide other support in the United...
Cubist Pharma, AstraZeneca sign exclusive deal to promote Merrem I.V. in US - Quick Facts (RTTNews) - Cubist Pharmaceuticals, Inc.(CBST) said that it signed an exclusive agreement with AstraZeneca Plc (AZN, AZN.L) to promote and provide other support in the United States for Merrem I.V., a broad spectrum I.V.
Cubist to promote AstraZeneca's broad spectrum antibiotic Cubist Pharmaceuticals has signed an exclusive agreement with AstraZeneca to promote and provide other support in the US for Merrem IV, an established broad spectrum IV antibiotic.Cubist will promote and support Merrem IV using...
Cubist Pharma, AstraZeneca sign exclusive deal to promote Merrem I.V. in US - Quick Facts (RTTNews) - Cubist Pharmaceuticals, Inc.(CBST) said that it signed an exclusive agreement with AstraZeneca Plc (AZN, AZN.L) to promote and provide other support in the United States for Merrem I.V., a broad spectrum I.V.
Cubist Pharmaceuticals (CBST) to Promote AstraZeneca's MERREM I.V. in the U.S Cubist Pharmaceuticals, Inc.(NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R) I.V., an established broad spectrum...
Cubist will promote AstraZeneca drug in the US Cubist Pharmaceuticals Inc.of Lexington said today that it has signed an exclusive agreement to promote an antibiotic from the British pharmaceutical giant AstraZeneca PLC in the United States.The antibiotic is MERREM I.V., and the...
